Topics

CNS Tumors | Treatment | Targeted therapy | ABM-1310

Home > Publications > Topics > CNS Tumors > Treatment > Targeted therapy > ABM-1310

Piha-Paul SA, De La Fuente M, Iwamoto F, Zhu JJ, Nagpal S, Braiteh F, Chandra S, Fu Y, Chen C, Yang Z, Tsai KK.
Phase I study of ABM-1310 as monotherapy and in combination with cobimetinib for BRAF-mutated advanced solid tumors: safety, efficacy, and dose expansion.
ESMO Open. 2026 Jan 27;11(2):106047. doi: 10.1016/j.esmoop.2025.106047. PMID: 41604813. Interventional study. ˍ